UY34295A - Nuevo esquema de administración de la n-hidroxi -4- {2-[3- (n,ndimetilaminometil)benzofuran -2- ilcarbonilamino]etoxi}benzamida - Google Patents
Nuevo esquema de administración de la n-hidroxi -4- {2-[3- (n,ndimetilaminometil)benzofuran -2- ilcarbonilamino]etoxi}benzamidaInfo
- Publication number
- UY34295A UY34295A UY0001034295A UY34295A UY34295A UY 34295 A UY34295 A UY 34295A UY 0001034295 A UY0001034295 A UY 0001034295A UY 34295 A UY34295 A UY 34295A UY 34295 A UY34295 A UY 34295A
- Authority
- UY
- Uruguay
- Prior art keywords
- ndimetilaminometil
- ilcarbonilamino
- benzamida
- etoxi
- benzofuran
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
N-hidroxi-4-{2-[3-(N,N-dimetilaminometil)benzofuran-2-ilcarbonilamino]etoxi}benzamida de fórmula I,o de una de sus sales de adición a un ácido o a una base farmacéuticamente aceptable, solo o en asociación con un tratamiento de cirugía, de quimioterapia, de hormonoterapia o con radioterapia para su utilización en el tratamiento del cáncer, caracterizada porque se administra durante 4 días consecutivos, estando seguido este periodo de 3 díasconsecutivos sin ninguna administración del compuesto de fórmula (I), con la salvedad de que el tratamiento de quimioterapia no es el FOLFOX. Medicamentos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161573585P | 2011-09-08 | 2011-09-08 | |
FR1102727 | 2011-09-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY34295A true UY34295A (es) | 2013-04-30 |
Family
ID=47830027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001034295A UY34295A (es) | 2011-09-08 | 2012-08-28 | Nuevo esquema de administración de la n-hidroxi -4- {2-[3- (n,ndimetilaminometil)benzofuran -2- ilcarbonilamino]etoxi}benzamida |
Country Status (17)
Country | Link |
---|---|
US (2) | US8883199B2 (es) |
EP (1) | EP2753322B1 (es) |
JP (1) | JP6014142B2 (es) |
KR (1) | KR20140073521A (es) |
CN (1) | CN103889409A (es) |
AR (1) | AR087803A1 (es) |
AU (2) | AU2012306122A1 (es) |
CA (1) | CA2847011A1 (es) |
HK (1) | HK1201150A1 (es) |
MX (1) | MX2014002663A (es) |
RU (1) | RU2600793C2 (es) |
SG (2) | SG10201505619QA (es) |
TW (1) | TWI544920B (es) |
UA (1) | UA113634C2 (es) |
UY (1) | UY34295A (es) |
WO (1) | WO2013034863A1 (es) |
ZA (1) | ZA201401710B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1611088B1 (en) | 2003-04-07 | 2009-06-17 | Pharmacyclics, Inc. | Hydroxamates as therapeutic agents |
DK2099442T3 (en) * | 2006-12-26 | 2015-02-16 | Pharmacyclics Inc | Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy |
EP2993473A1 (en) * | 2007-01-30 | 2016-03-09 | Pharmacyclics, Inc. | Methods for determining cancer resistance to histone deacetylase inhibitors |
US8603521B2 (en) | 2009-04-17 | 2013-12-10 | Pharmacyclics, Inc. | Formulations of histone deacetylase inhibitor and uses thereof |
MX365393B (es) | 2011-09-13 | 2019-05-31 | Pharmacyclics Llc | Formulaciones de inhibidor de histona deacetilasa en combinación con bendamustina y usos de las mismas. |
AR097204A1 (es) | 2013-08-02 | 2016-02-24 | Pharmacyclics Inc | Métodos de tratamiento de tumores sólidos |
KR101684854B1 (ko) * | 2016-06-13 | 2016-12-09 | 아이오틴 주식회사 | 보호자 알림기능을 이용한 휴대용 스마트약통 및 이를 포함하는 복용시간 알림시스템 |
CN114146181B (zh) * | 2021-10-29 | 2022-09-09 | 徐诺药业(南京)有限公司 | 含Pan-HDAC和免疫检查点抑制剂的组合及应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL163923A0 (en) * | 2002-03-28 | 2005-12-18 | Tanabe Seiyaku Co | Benzofuran derivatives |
WO2003088954A1 (en) * | 2002-04-15 | 2003-10-30 | Sloan-Kettering Institute For Cancer Research | Combination therapy for the treatment of cancer |
EP1611088B1 (en) * | 2003-04-07 | 2009-06-17 | Pharmacyclics, Inc. | Hydroxamates as therapeutic agents |
WO2006116341A1 (en) * | 2005-04-21 | 2006-11-02 | Alza Corporation | Method for treating advanced ovarian cancer with doxorubicin entrapped in liposomes |
-
2012
- 2012-08-28 UY UY0001034295A patent/UY34295A/es not_active Application Discontinuation
- 2012-09-06 TW TW101132604A patent/TWI544920B/zh not_active IP Right Cessation
- 2012-09-06 US US13/605,116 patent/US8883199B2/en active Active
- 2012-09-07 WO PCT/FR2012/052004 patent/WO2013034863A1/fr active Application Filing
- 2012-09-07 SG SG10201505619QA patent/SG10201505619QA/en unknown
- 2012-09-07 JP JP2014529056A patent/JP6014142B2/ja active Active
- 2012-09-07 KR KR1020147009191A patent/KR20140073521A/ko active Search and Examination
- 2012-09-07 AU AU2012306122A patent/AU2012306122A1/en not_active Abandoned
- 2012-09-07 AR ARP120103299A patent/AR087803A1/es unknown
- 2012-09-07 SG SG11201400120UA patent/SG11201400120UA/en unknown
- 2012-09-07 MX MX2014002663A patent/MX2014002663A/es unknown
- 2012-09-07 UA UAA201403500A patent/UA113634C2/uk unknown
- 2012-09-07 CN CN201280041854.3A patent/CN103889409A/zh active Pending
- 2012-09-07 RU RU2014113399/15A patent/RU2600793C2/ru not_active IP Right Cessation
- 2012-09-07 EP EP12769146.7A patent/EP2753322B1/fr active Active
- 2012-09-07 CA CA2847011A patent/CA2847011A1/fr not_active Abandoned
-
2014
- 2014-03-07 ZA ZA2014/01710A patent/ZA201401710B/en unknown
- 2014-10-09 US US14/510,369 patent/US20150024040A1/en not_active Abandoned
- 2014-12-23 HK HK14112851.7A patent/HK1201150A1/xx unknown
-
2016
- 2016-04-22 AU AU2016202594A patent/AU2016202594B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
AR087803A1 (es) | 2014-04-16 |
RU2014113399A (ru) | 2015-10-20 |
NZ622112A (en) | 2016-07-29 |
JP6014142B2 (ja) | 2016-10-25 |
SG11201400120UA (en) | 2014-09-26 |
TW201313228A (zh) | 2013-04-01 |
UA113634C2 (uk) | 2017-02-27 |
AU2016202594B2 (en) | 2017-09-14 |
HK1201150A1 (en) | 2015-08-28 |
MX2014002663A (es) | 2014-08-29 |
US20130064880A1 (en) | 2013-03-14 |
RU2600793C2 (ru) | 2016-10-27 |
SG10201505619QA (en) | 2015-08-28 |
KR20140073521A (ko) | 2014-06-16 |
EP2753322B1 (fr) | 2016-08-03 |
EP2753322A1 (fr) | 2014-07-16 |
CN103889409A (zh) | 2014-06-25 |
CA2847011A1 (fr) | 2013-03-14 |
JP2014526457A (ja) | 2014-10-06 |
US20150024040A1 (en) | 2015-01-22 |
AU2012306122A1 (en) | 2014-03-13 |
WO2013034863A1 (fr) | 2013-03-14 |
ZA201401710B (en) | 2015-01-28 |
TWI544920B (zh) | 2016-08-11 |
US8883199B2 (en) | 2014-11-11 |
AU2016202594A1 (en) | 2016-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY34295A (es) | Nuevo esquema de administración de la n-hidroxi -4- {2-[3- (n,ndimetilaminometil)benzofuran -2- ilcarbonilamino]etoxi}benzamida | |
UY34365A (es) | Compuestos heterociclicos | |
UY34342A (es) | ?derivados de pirrolopirimidina y purina?. | |
UY34602A (es) | ?Derivados de bencimidazolil- e imidazopiridinil-metilamina? | |
UY34442A (es) | 2-tiopirimidinonas. | |
UY34523A (es) | Derivados de betulina | |
CL2012002979A1 (es) | Derivados de n3-sustituido-n1-sulfonil-5-fluorpirimidinona. | |
CR20130539A (es) | Triazolopiridinas | |
CR20120295A (es) | Triazolopiridinas | |
UY33936A (es) | Derivados de fluoro-piridinona útiles como agentesantibacterianos. | |
UY33883A (es) | Novedosos derivados heterocíclicos | |
UY33943A (es) | Derivados espirocíclicos de isoxazolina como agentes antiparasitarios. | |
UY34350A (es) | Derivados de pirazolquinolinona, su preparación y su uso terapéutico. | |
CY1117163T1 (el) | Ιμιδαζοπυριδαζινες ως αναστολεις κινασης ακτ | |
UY34251A (es) | derivados de isoxazolina como compuestos insecticidas. | |
UY34654A (es) | Inhibidores de la beta-secretasa | |
UY34057A (es) | Inhibidores del virus de la hepatitis c | |
CR20120637A (es) | Triazolopiridinas sustituidas | |
UY34013A (es) | ?compuestos de cromenona con actividad anti-tumoral?. | |
UY34314A (es) | Derivados de anilina, su preparación y su aplicación terapéutica. | |
UY33642A (es) | Formula mejorada de herbicida | |
UY34329A (es) | Compuestos de triazolopiridina | |
UY33976A (es) | Derivados de pirazolo-pirimidina. | |
UY34469A (es) | Composicion herbicida | |
UY34349A (es) | OCTAHIDROPIRROLO[1,2-a]PIRAZINA SULFONAMIDAS SUSTITUIDAS COMO BLOQUEADORES DE CANALES DE CALCIO |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RDES | Application refused |
Effective date: 20211015 |